Decreased salivary matrix metalloproteinase-8 reflecting a defensive potential in juvenile parotitis

International Journal of Pediatric Otorhinolaryngology

Volumn 80, Issue , 2016, Pages 74-77

  Saarinen, Riitta ^a   Pitkäranta, Anne ^a   Kolho, Kaija Leena ^a,b   Tervahartiala, Taina ^a   Sorsa, Timo ^a,c   Lauhio, Anneli ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Matrix metalloproteinase; MMP 8; MMP 9; Parotitis

Indexed keywords

C REACTIVE PROTEIN; GELATINASE B; HUMAN NEUTROPHIL ELASTASE; LEUKOCYTE ELASTASE; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; PEROXIDASE; TIMP1 PROTEIN, HUMAN;

ADOLESCENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; GINGIVITIS; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; JUVENILE; LEUKOCYTE COUNT; MALE; MOUTH FLORA; PAROTITIS; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVA LEVEL; TERTIARY CARE CENTER; UPREGULATION; ADULT; CASE CONTROL STUDY; ENZYMOLOGY; METABOLISM; PRESCHOOL CHILD; SALIVA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GINGIVITIS; HUMANS; LEUKOCYTE ELASTASE; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; PAROTITIS; PEROXIDASE; SALIVA; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84962020067     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2015.11.012     Document Type: Article

References (34)

1. Peltola H., Jokinen S., Paunio M., Hovi T., Davidkin I. Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Lancet Infect. Dis. 2008, 8:796-803.
2. Saarinen R., Kolho K.L., Davidkin I., Pitkaranta A. The clinical picture of juvenile parotitis in a prospective setup. Acta Paediatr. 2013, 102(2):177-181.
3. Davidkin I., Jokinen S., Paananen A., Leinikki P., Peltola H. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella. J. Infect. Dis. 2005, 191:719-723.
4. Isaacs D. Recurrent parotitis. J. Paediatr. Child Health 2002, 38:92-94.
5. Saarinen R., Kolho K.L., Pitkaranta A. Cases presenting as parotid abscesses in children. Int. J. Pediatr. Otorhinolaryngol. 2007, 71:897-901.
6. Kolho K.L., Saarinen R., Paju A., Stenman J., Stenman U.H., Pitkaranta A. New insights into juvenile parotitis. Acta Paediatr. 2005, 94:1566-1570.
7. Vinagre C., Martinez M.J., Avendano L.F., Landaeta M., Pinto M.E. Virology of infantile chronic recurrent parotitis in Santiago de Chile. J. Med. Virol. 2003, 70:459-462.
8. Sorsa T., Tjaderhane L., Konttinen Y.T., Lauhio A., Salo T., Lee H.M., et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann. Med. 2006, 38:306-321.
9. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
10. Owen C.A., Hu Z., Lopez-Otin C., Shapiro S.D. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J. Immunol. 2004, 172:7791-7803.
11. Lauhio A., Salo T., Ding Y., Konttinen Y.T., Nordstrom D., Tschesche H., et al. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin. Exp. Immunol. 1994, 98:21-28.
12. Lauhio A., Konttinen Y.T., Tschesche H., Nordstrom D., Salo T., Lahdevirta J., et al. Reduction of matrix metalloproteinase 8-neutrophil collagenase levels during long-term doxycycline treatment of reactive arthritis. Antimicrob. Agents Chemother. 1994, 38:400-402.
13. Van Lint P., Libert C. Matrix metalloproteinase-8: cleavage can be decisive. Cytokine Growth Factor Rev. 2006, 17:217-223.
14. Hastbacka J., Hynninen M., Kolho E., Pettila V., Tervahartiala T., Sorsa T., et al. Collagenase 2/matrix metalloproteinase 8 in critically ill patients with secondary peritonitis. Shock 2007, 27:145-150.
15. Kuula H., Salo T., Pirila E., Tuomainen A.M., Jauhiainen M., Uitto V.J., et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis. Infect. Immun. 2009, 77:850-859.
16. Piirila P., Lauhio A., Majuri M.L., Meuronen A., Myllarniemi M., Tervahartiala T., et al. Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma. Allergy 2010, 65(1):61-68.
17. Vanlaere I., Libert C. Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin. Microbiol. Rev. 2009, 22:224-239. (Table of Contents).
18. Vandenbroucke R.E., Dejonckheere E., Van Lint P., Demeestere D., Van Wonterghem E., Vanlaere I., et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases. J. Neurosci. 2012, 32:9805-9816.
19. Morales-Bozo I., Landaeta M., Urzua-Orellana B., Retamales P. Association between the occurrence of matrix metalloproteinases 2 and 9 in parotid saliva with the degree of parotid gland damage in juvenile recurrent parotitis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2008, 106:377-383.
20. Morales-Bozo I., Urzua-Orellana B., Landaeta M., Montalban R., Torres J., Pinochet A., et al. Molecular alterations of parotid saliva in infantile chronic recurrent parotitis. Pediatr. Res. 2007, 61:203-208.
21. Rathnayake N., Akerman S., Klinge B., Lundegren N., Jansson H., Tryselius Y., et al. Salivary biomarkers for detection of systemic diseases. PLoS ONE 2013, 8:e61356.
22. Rathnayake N., Akerman S., Klinge B., Lundegren N., Jansson H., Tryselius Y., et al. Salivary biomarkers of oral health: a cross-sectional study. J. Clin. Periodontol. 2013, 40:140-147.
23. Uitto V.J., Suomalainen K., Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J. Periodontal. Res. 1990, 25:135-142.
24. Gursoy U.K., Kononen E., Huumonen S., Tervahartiala T., Pussinen P.J., Suominen A.L., et al. Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J. Clin. Periodontol. 2013, 40:18-25.
25. Rautelin H.I., Oksanen A.M., Veijola L.I., Sipponen P.I., Tervahartiala T.I., Sorsa T.A., et al. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis. Ann. Med. 2009, 41:208-215.
26. Salminen A., Astrom P., Metso J., Soliymani R., Salo T., Jauhiainen M., et al. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity. FASEB J. 2015, 29(4):1435-1445.
27. Astrom P., Pirila E., Lithovius R., Heikkola H., Korpi J.T., Hernandez M., et al. Matrix metalloproteinase-8 regulates transforming growth factor-beta1 levels in mouse tongue wounds and fibroblasts in vitro. Exp. Cell Res. 2014, 328:217-227.
28. Hernandez M., Gamonal J., Salo T., Tervahartiala T., Hukkanen M., Tjaderhane L., et al. Reduced expression of lipopolysaccharide-induced CXC chemokine in Porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice. J. Periodontal. Res. 2011, 46:58-66.
29. Lauhio A., Hastbacka J., Pettila V., Tervahartiala T., Karlsson S., Varpula T., et al. Serum MMP-8, -9 and TIMP-1 in sepsis: high serum levels of MMP-8 and TIMP-1 are associated with fatal outcome in a multicentre, prospective cohort study. Hypothetical impact of tetracyclines. Pharmacol. Res. 2011, 64:590-594.
30. Fink M.P. Matrix metalloproteinase-8 as a potential drug target for the therapy of sepsis. Crit. Care Med. 2012, 40:655-656.
31. Solan P.D., Dunsmore K.E., Denenberg A.G., Odoms K., Zingarelli B., Wong H.R. A novel role for matrix metalloproteinase-8 in sepsis. Crit. Care Med. 2012, 40:379-387.
32. Lauhio A., Rezes S., Tervahartiala T., Sziklai I., Pitkaranta A., Sorsa T. Matrix metalloproteinase-8/collagenase-2 in childhood otitis media with effusion. Ann. Med. 2012, 44:93-99.
33. Lauhio A., Oksi J., Tervahartiala T., Hytönen J., Pitkäranta A., Sorsa T. Serum matrix metalloproteinase-8 and -9 levels in disseminated Lyme borreliosis with specil reference to arthritis. CCAAS Bio. 2012, 2:68-74.
34. Weiss S.J. Tissue destruction by neutrophils. N. Engl. J. Med. 1989, 320:365-376.